152 related articles for article (PubMed ID: 2575061)
21. Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis.
Koop H; Arnold R
Dig Dis Sci; 1991 May; 36(5):552-7. PubMed ID: 1673654
[TBL] [Abstract][Full Text] [Related]
22. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
Sontag SJ
Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
[TBL] [Abstract][Full Text] [Related]
23. The clinical utility and safety of omeprazole.
Walan A
Scand J Gastroenterol Suppl; 1989; 166():140-4; discussion 145. PubMed ID: 2574908
[TBL] [Abstract][Full Text] [Related]
24. [Omeprazole in the therapy of acid-induced diseases].
Simon B; Dammann HG; Müller P
Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
[TBL] [Abstract][Full Text] [Related]
25. Drug therapy of reflux oesophagitis: an update.
Tytgat GN
Scand J Gastroenterol Suppl; 1989; 168():38-49. PubMed ID: 2575792
[TBL] [Abstract][Full Text] [Related]
26. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
[TBL] [Abstract][Full Text] [Related]
27. Reflux esophagitis.
Tytgat GN; Nio CY; Schotborgh RH
Scand J Gastroenterol Suppl; 1990; 175():1-12. PubMed ID: 1978403
[TBL] [Abstract][Full Text] [Related]
28. [Omeprazole and maintenance treatment: new concepts for traditional therapies?].
Díaz de Rojas F; Ponce García J
An Med Interna; 1992 Sep; 9(9):450-4. PubMed ID: 1391583
[TBL] [Abstract][Full Text] [Related]
29. Towards an increased efficacy of acid inhibition in the treatment of erosive oesophagitis.
Lambert R
J Gastroenterol Hepatol; 1996 Oct; 11(10):897-9. PubMed ID: 8912122
[No Abstract] [Full Text] [Related]
30. Management of peptic oesophageal stricture.
Carr SJ; Wicks AC
Dig Dis; 1993; 11(4-5):197-205. PubMed ID: 7900938
[TBL] [Abstract][Full Text] [Related]
31. [Therapeutic achlorhydria: for which diseases, when and for how long?].
Koop H; Arnold R
Dtsch Med Wochenschr; 1988 Mar; 113(13):516-8. PubMed ID: 2894969
[No Abstract] [Full Text] [Related]
32. Omeprazole: implications for therapy of peptic ulcer and reflux oesophagitis.
Bium AL
Digestion; 1989; 44 Suppl 1():87-91. PubMed ID: 2691314
[TBL] [Abstract][Full Text] [Related]
33. Omeprazole in the long-term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose-finding study.
Laursen LS; Havelund T; Bondesen S; Hansen J; Sanchez G; Sebelin E; Fenger C; Lauritsen K
Scand J Gastroenterol; 1995 Sep; 30(9):839-46. PubMed ID: 8578181
[TBL] [Abstract][Full Text] [Related]
34. Famotidine 40mg B.I.D. in the treatment of reflux oesophagitis.
Ahmed W; Qureshi H; Alam SE; Zuberi SJ
J Pak Med Assoc; 1995 Sep; 45(9):241-3. PubMed ID: 8683830
[TBL] [Abstract][Full Text] [Related]
35. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
[TBL] [Abstract][Full Text] [Related]
36. [Medical treatment of reflux peptic esophagitis: literature review].
Van Gossum M
Rev Med Brux; 1994; 15(1):20-4. PubMed ID: 7910701
[TBL] [Abstract][Full Text] [Related]
37. Treatment of gastroesophageal reflux: the role of proton pump inhibitors.
Schulman MI; Orlando RC
Adv Intern Med; 1995; 40():273-302. PubMed ID: 7747649
[No Abstract] [Full Text] [Related]
38. H+/K+-adenosine triphosphatase inhibitors. A new approach to the treatment of acid-peptic diseases.
Lamers CB
Digestion; 1989; 44 Suppl 1():92-5. PubMed ID: 2691316
[TBL] [Abstract][Full Text] [Related]
39. [Reflux esophagitis: therapeutic indications].
Cloarec D; Bruley des Varannes S; Galmiche JP
Rev Prat; 1988 Feb; 38(4):237-48. PubMed ID: 2895495
[No Abstract] [Full Text] [Related]
40. Omeprazole in the treatment of patients with severe reflux oesophagitis not responding to H2-receptor antagonists and ineligible for surgery.
Fiasse R; Druez P; Coppens JP; Delhaze M; Fabre C; Pauwels S; Dive C
Acta Gastroenterol Belg; 1990; 53(5-6):573-84. PubMed ID: 2130587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]